Joshua Russo's Avatar

Joshua Russo

@jrpcfer.bsky.social

Prostate cancer researcher at Beth Israel Deaconess Medical Center/Instructor at Harvard Medical School.

72 Followers  |  113 Following  |  2 Posts  |  Joined: 16.01.2025  |  1.772

Latest posts by jrpcfer.bsky.social on Bluesky

Where does TrumpElon think innovation for all their favorite biotech corporations comes from? PCR only exists because somebody was looking for bacteria in hot springs at Yellowstone. I’m just a private practice ophthalmologist who barely understands p values but even I know this shit is important.

13.03.2025 14:12 β€” πŸ‘ 603    πŸ” 142    πŸ’¬ 16    πŸ“Œ 1
Post image Post image

Maybe the crisis in seabirds with multi-organ failure from exposure to plastics will help raise awareness of their serious hazard and lead to action
science.org/doi/10.1126/...

12.03.2025 20:52 β€” πŸ‘ 378    πŸ” 103    πŸ’¬ 18    πŸ“Œ 9
Post image Post image

About $74 million in US govt funding (including NIH) went into developing enzalutamide - a multibillion dollar drug that prolonged life for countless men with prostate cancer. Why would anyone cut this support? We need more, not less! @ascocancer.bsky.social @theaacr.bsky.social

23.02.2025 19:11 β€” πŸ‘ 12    πŸ” 6    πŸ’¬ 1    πŸ“Œ 0

Also, this is 1st post on the new platform.

Already see alot of familiar faces. Hope the #prostate #cancer #research community continues to grow. 🀞

19.01.2025 13:56 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Increased nuclear factor I-mediated chromatin access drives transition to androgen receptor splice variant dependence in prostate cancer - PubMed Androgen receptor (AR) splice variants, of which ARv7 is the most common, are increased in castration-resistant prostate cancer, but the extent to which they drive AR activity is unclear. We generated...

Happy to finally have this work out. Enza-resistance in PCa via upregulation of ARv7 and increased chromatin accessibility.

Congrats to lead author (and newly minted PCF YI) Larysa Poluben! She put a tremendous amount of work into this and deserves all the πŸ‘πŸ‘πŸ‘.

pubmed.ncbi.nlm.nih.gov/39709604/

19.01.2025 13:56 β€” πŸ‘ 4    πŸ” 1    πŸ’¬ 2    πŸ“Œ 0

@jrpcfer is following 20 prominent accounts